SHINPOONG PHARMACEUTICAL CO.,LTD Logo

SHINPOONG PHARMACEUTICAL CO.,LTD

R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.

019170 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안산시 단원구 원시로 7, 안산시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Shinpoong Pharmaceutical Co., Ltd. is an R&D-oriented multinational pharmaceutical company that manufactures and markets a range of pharmaceutical products, active pharmaceutical ingredients (APIs), and finished drugs. The company is committed to advancing pharmaceutical technologies and produces various remedy drugs and specialized medical products, such as its anti-adhesion barrier, Medicurtain. With a global presence that includes multiple manufacturing sites and international supply agreements, the company serves both domestic and overseas markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-06-27 00:00
Regulatory News Service
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_국내특허취득)
Korean 7.4 KB
2025-06-16 00:00
Regulatory News Service
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_특허취득)
Korean 7.5 KB
2025-05-30 00:00
Regulatory News Service
불성실공시법인지정
Korean 7.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.7 MB
2025-05-15 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.7 MB
2025-05-12 00:00
Regulatory News Service
불성실공시법인지정예고
Korean 6.0 KB
2025-05-08 00:00
Legal Proceedings Report
횡령ㆍ배임사실확인
Korean 9.5 KB
2025-04-03 00:00
Regulatory News Service
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M002주의 임상 3상 시험 Topline 결과 발표)
Korean 14.8 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.7 KB
2025-03-20 00:00
Annual Report
[첨부추가]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 20.9 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.8 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 144.2 KB

Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.